EUVIMEDEUVIMED entdecken
Open Access

Except for Robust Outliers, Rapamycin Increases Lesion Burden in a Murine Model of Cerebral Cavernous Malformations

Roberto J Alcazar-Felix, Robert Shenkar, Christian R Benavides, Akash Bindal, Abhinav Srinath, Ying Li, Serena Kinkade, Tatiana Terranova, Evon DeBose-Scarlett, Rhonda Lightle, Dorothy DeBiasse, Hanadi Almazroue und 9 weitere

Translational Stroke Research · 2025-06 · 16 (3) · 859-867

DOI: 10.1007/s12975-024-01270-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Stroke Research, online erschienen am 09.07.2024. Verfasst von Roberto J Alcazar-Felix und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, Pritzker School of Medicine and Biological Sciences Division, University of Chicago, Chicago, IL, 60637, USA. Hauptthemen laut MEDLINE: Sirolimus, Hemangioma, Cavernous, Central Nervous System. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NICHD NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SirolimusHemangioma, Cavernous, Central Nervous SystemAnimalsDisease Models, AnimalMiceClass I Phosphatidylinositol 3-KinasesMale

Stichwörter der Autor:innen

CCMCerebral cavernous malformationMouseROCK inhibitorRapamycinStroke

Substanzen

SirolimusClass I Phosphatidylinositol 3-KinasesPik3ca protein, mouse

Autor:innen und Institutionen

  • Department of Neurological Surgery, Pritzker School of Medicine and Biological Sciences Division, University of Chicago, Chicago, IL, 60637, USA.
  • Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC, 27710, USA.
  • Department of Neurological Surgery, Pritzker School of Medicine and Biological Sciences Division, University of Chicago, Chicago, IL, 60637, USA. iawad@uchicago.edu.

Förderung

  • NINDS NIH HHS
  • NICHD NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Alcazar-Felix, R. J., Shenkar, R., Benavides, C. R., Bindal, A., Srinath, A., Li, Y., Kinkade, S., Terranova, T., DeBose-Scarlett, E., Lightle, R., DeBiasse, D., Almazroue, H., Cruz, D. V., Romanos, S., Jhaveri, A., Koskimäki, J., Hage, S., Bennett, C., Girard, R., …, & Awad, I. A. (2025). Except for Robust Outliers, Rapamycin Increases Lesion Burden in a Murine Model of Cerebral Cavernous Malformations. Translational Stroke Research, 16(3), 859-867. https://doi.org/10.1007/s12975-024-01270-9

Vancouver

Alcazar-Felix RJ, Shenkar R, Benavides CR, Bindal A, Srinath A, Li Y, et al. Except for Robust Outliers, Rapamycin Increases Lesion Burden in a Murine Model of Cerebral Cavernous Malformations. Translational Stroke Research. 2025;16(3):859-867. doi:10.1007/s12975-024-01270-9

BibTeX
@article{AlcazarFelix2025,
  author = {Alcazar-Felix, Roberto J and Shenkar, Robert and Benavides, Christian R and Bindal, Akash and Srinath, Abhinav and Li, Ying and Kinkade, Serena and Terranova, Tatiana and DeBose-Scarlett, Evon and Lightle, Rhonda and DeBiasse, Dorothy and Almazroue, Hanadi and Cruz, Diana Vera and Romanos, Sharbel and Jhaveri, Aditya and Koskimäki, Janne and Hage, Stephanie and Bennett, Carolyn and Girard, Romuald and Marchuk, Douglas A and Awad, Issam A},
  title = {Except for Robust Outliers, Rapamycin Increases Lesion Burden in a Murine Model of Cerebral Cavernous Malformations},
  journal = {Translational Stroke Research},
  year = {2025},
  volume = {16},
  number = {3},
  pages = {859--867},
  doi = {10.1007/s12975-024-01270-9}
}
Kostenlos starten →